Article
Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism.
Neurobiology of disease - 1 Nov 2006
Darreh-Shori T, Brimijoin S, Kadir A, Almkvist O, Nordberg A
Abstract excerpt
Butyrylcholinesterase (BuChE) is increased in the cerebral cortex of Alzheimer's disease (AD) patients, particularly those carrying epsilon4 allele of the apolipoprotein E gene (ApoE) and certain BuChE variants that predict increased AD risk and poor response to anticholinesterase therapy. We measured BuChE activity and protein level in CSF of eighty mild AD patients in relation to age, gender, ApoE epsilon4...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
